News

Tharimmune, Inc., (Nasdaq:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently ...
The recall has been categorized as "Class II," meaning any contaminated product could cause "temporary or medically ...
Missouri’s biggest city filed a lawsuit in federal court in Washington, D.C., on Thursday against HHS Secretary Robert F.
After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and ...
Haitao Li, chair of the supply chain analytics department at the University of Missouri-St. Louis, says that the Trump ...
Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug ...
Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...
U.S. health officials on Tuesday said they would phase out petroleum-based artificial colors in the nation’s food supply, ...
The Trump administration plans to eliminate artificial food dyes linked to health risks from the U.S. food supply ...